Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms of Precise Immune Cell Phenotyping and Prognostic Prediction in Severe Infection

NCT07332793 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Wenzhou Medical University as lead sponsor.

NCT NCT07332793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07332793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms of Precise Immune Cell Phenotyping and Prognostic Prediction in Severe Infection
Lead sponsor
Second Affiliated Hospital of Wenzhou Medical University
Phase
Observational
Overall status
Not yet recruiting
Start date
January 15, 2026
Completion date
January 15, 2028
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis